Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03178071
Brief Title: Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive

First Submitted : June 2, 2017
First Submitted that Met QC Criteria : June 2, 2017
First Posted : June 6, 2017

Last Update Submitted that Met QC Criteria : October 31, 2019
Last Update Posted : November 4, 2019